Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

11 results
Display

Health Economics and Outcomes Research

Kim CM

Health conomics refers to the scientific discipline that compares the value of one healthcare program to another. It is a sub-discipline of Micro-economics. A health economic study evaluates the cost...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Guidelines for Economic Evaluation of Pharmaceuticals in Korea

Bae EY

An economic evaluation is required in order to apply to the Health Insurance Review and Assessment Service (HIRA) for a listing in the national drug formulary. To assist companies in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Use of Economic Evaluation in the Listing and Pricing of Pharmaceuticals

Lee TJ

To curb a rapid increase in expenditures for pharmaceuticals, the Korean government introduced a positive list system and a negotiation process for drug prices at the end of 2006. Economic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current State and Challenges of Pharmacoeconomic Evaluation in Korea

Choi SE

Since the positive listing system for prescription drug reimbursement has been introduced in Korea, the number of pharmacoeconomic evaluation studies has increased. However it is not clear if the quality...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug Utilization Review

Bae SC

Drug utilization review (DUR) is one of the approaches to improve quality of health care and reduce its costs. DUR programs have been defined as "structured, ongoing initiatives that interpret...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How to choose the Antidepressants in Clinical Practice?

Kwon JS

  • KMID: 2071106
  • Korean J Psychopharmacol.
  • 2000 Mar;11(1):3-6.
Newer antidepressants of various types continue to be developed for the treatment of depression recently. While the physicians have a good chance of choosing the diverse antidepressant, they have difficulties...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cost-Identification Analysis between Amphotericin B deoxycholate and Intravenous Itraconazole in the Empirical Treatment of Febrile Neutropenic Patients:Preliminary Report

Lee DG, Song YG, Yoo JH, Choi SM, Choi JH, Park SH, Shin WS

  • KMID: 2285111
  • Infect Chemother.
  • 2004 Oct;36(5):304-310.
BACKGROUND: The increasing incidence of systemic fungal infections and the rising medical cost have focused the need to determine the economic issues of antifungal agents. Nevertheless there have been only...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The need for redesigned pharmacy practice courses in Pakistan: the perspectives of senior pharmacy students

Umair Khan M, Ahmad A, Hussain K, Salam A, Hasnain ZU, Patel I

PURPOSE: In Pakistan, courses in pharmacy practice, which are an essential component of the PharmD curriculum, were launched with the aim of strengthening pharmacy practice overall and enabling pharmacy students...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Retrospective Pharmacoeconomic Study of Risperidone versus Olanzapine

Suh GH, Lee TJ

  • KMID: 1996825
  • Korean J Psychopharmacol.
  • 2003 Jun;14(2):145-153.
OBJECTIVE: The study aims to compare daily treatment costs of risperidone and olanzapine in the Korean RODOS data. METHODS: Retrospective inpatient chart review yielded pharmacoeconomic data of 1096 patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cost-Effectiveness of Denosumab for Post-Menopausal Osteoporosis in South Korea

Bae G, Kwon HY

BACKGROUND: In South Korea, 22.3% of women ≥50 years of age and 37% of women ≥70 years of age visit the doctor to obtain treatment for osteoporosis. According to the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risperidone: the Korean Experience in the Treatment of Patients with Schizophrenic Disorder

Yoon JS, Bae KL

  • KMID: 1856367
  • Korean J Psychopharmacol.
  • 2003 Feb;14(Suppl):16-31.
Since the introduction in 1996 of the novel antipsychotic risperidone in Korea, clinical experiences with this agent for the treatment of schizophrenia have been accumulated. This article attempts to review...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr